onr:"swepub:oai:prod.swepub.kib.ki.se:1936261"
Search: onr:"swepub:oai:prod.swepub.kib.ki.se:1936261" > Loss of parafibromi...
- 1 of 1
- Previous record
- Next record
- To hitlist
- Juhlin, CKarolinska Institutet (author)
Loss of parafibromin expression in a subset of parathyroid adenomas
- Article/chapterEnglish2006
Publisher, publication year, extent ...
- Bioscientifica,2006
Numbers
- LIBRIS-ID:oai:prod.swepub.kib.ki.se:1936261
- http://kipublications.ki.se/Default.aspx?queryparsed=id:1936261URI
- https://doi.org/10.1677/erc.1.01058DOI
Supplementary language notes
- Language:English
- Summary in:English
Part of subdatabase
- SwePubSwePub
Classification
Notes
- Inactivation of the hyperparathyroidism–jaw tumour syndrome (HPT– JT) gene, HRPT2, was recently established as a genetic mechanism in the development of parathyroid tumours. Its encoded protein parafibromin has tumour-suppressor properties that play an important role in tumour development in the parathyroids, jaws and kidneys. Inactivating HRPT2 mutations are common in HPT– JT and parathyroid carcinomas, and have been described in a few cases of parathyroid adenomas with cystic features. In this study, 46 cases of cystic parathyroid adenomas previously investigated for HRPT2 mutations were characterized with regard to MEN1 gene mutations, cyclin D1 expression and parafibromin expression. In normal tissues and cell lines, parafibromin was ubiquitously expressed. Furthermore, parafibromin was detected as a dominating nuclear and a weaker cytoplasmic signal in transfected cell lines. In the three parathyroid tumours with inactivating HRPT2 mutations parafibromin expression was not detectable, and in one of two cases with aberrantly sized parafibromin the protein was delocalized. Both high and low cyclin D1 levels were found among HRPT2-mutated and -unmutated tumours, suggesting that these events are not mutually exclusive in parathyroid tumour development. The presented data suggest that in the majority of benign parathyroid tumours the expression of parafibromin remains unaltered, while the loss of parafibromin expression is strongly indicative of gene inactivation through mutation of the HRPT2 gene.
Added entries (persons, corporate bodies, meetings, titles ...)
- Larsson, CKarolinska Institutet (author)
- Yakoleva, T (author)
- Leibiger, IKarolinska Institutet (author)
- Leibiger, BKarolinska Institutet (author)
- Alimov, A (author)
- Weber, G (author)
- Hoog, AKarolinska Institutet (author)
- Villablanca, AKarolinska Institutet (author)
- Karolinska Institutet (creator_code:org_t)
Related titles
- In:Endocrine-related cancer: Bioscientifica13:2, s. 509-5231351-00881479-6821
Internet link
Find in a library
- Endocrine-related cancer (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Juhlin, C
- Larsson, C
- Yakoleva, T
- Leibiger, I
- Leibiger, B
- Alimov, A
- show more...
- Weber, G
- Hoog, A
- Villablanca, A
- show less...
- Articles in the publication
- Endocrine-relate ...
- By the university
- Karolinska Institutet
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
